Target intelligence / Profile preview

Inverse electron demand Diels–Alder reaction (IEDDA)

Target
IEDDA
Molecular classification
Other, Bioorthogonal reaction, Click chemistry mechanism
01

Overview

The Inverse electron demand Diels–Alder reaction (IEDDA) is a synthetic organic chemistry reaction involving a cycloaddition between an electron-poor diene (often tetrazine) and an electron-rich dienophile (often a strained alkene such as trans-cyclooctene). The IEDDA is renowned for its rapid kinetics, irreversible nature due to nitrogen release, catalyst-free conditions, and excellent chemical selectivity, making it ideal for applications in bioorthogonal chemistry—reactions that occur specifically in biological environments without interfering with native biochemistry. Typical applications include: Live-cell and animal imaging via site-specific labeling, Drug delivery and activation, Metabolic glycoengineering, Controlled protein or small molecule activation ("decaging"), and synthesis of biomaterials. IEDDA is not a biological macromolecule, nor is it a receptor, enzyme, or traditional drug target. Rather, it is a chemistry platform/tool enabling manipulation of biological molecules for research, diagnostics, and therapy.

Other names
DAINVIEDDAinverse-demand Diels-Alder reactioninverse-electron-demand Diels-Alder cycloaddition
02

Mechanism of action

Bioorthogonal cleavage: IEDDA enables rapid, catalyst-free covalent bond formation between a tetrazine (electron-poor diene) and a strained alkene (electron-rich dienophile), sometimes allowing removal ("decaging") or activation of a functional group on a biomolecule. Molecular imaging and probe generation: click-to-label or activate fluorescent reporters or drugs for cell/animal imaging.

03

Biological functions

Chemical ligationBioorthogonal cleavage or decagingImaging and probe activation
04

Disease associations

CancerImaging in diseaseDrug delivery
05

Safety considerations

Immunogenicity and toxicity of probesOff-target modification
06

Interacting drugs

^18^F-transcyclooctene

3 more in the full profile.

Beyond the preview

Go deeper on Inverse electron demand Diels–Alder reaction (IEDDA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inverse electron demand Diels–Alder reaction (IEDDA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call